Provention Bio

/Provention Bio

Follow-on

Provention Bio

Biopharmaceutical

We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and innovative approaches aimed at intercepting and preventing immune-mediated diseases.

Symbol

PRVB

Last Closing Price
$17.70

Shares
6,000,000

Anticipated Date
January 14, 2021

Underwriters
LEERINK SWANN & COMPANY

This offering is no longer available

To view the prospectus for Provention Bio, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277